SCR-LIP-000480 · Claim · machine-readable JSON →

A narrative review reports that ketogenic/low-carbohydrate diets in women with lipedema reduce insulin resistance (lower HOMA-IR and basal insulin), promote weight loss (cited meta-analysis: BMI reduction of 4.23 kg/m² and 7.94 kg over ~15.85 weeks), and a controlled study showed low-carb diet significantly reduced calf subcutaneous adipose tissue area and pain (NRS), though the authors note data are limited and long-term studies are needed.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2025Therapeutic Applications of Ketogenic Diets in Lipedema: A Narrative Review of Current Evidence (2025) · consistent

Evidence (1)

Context (PECO)

Populationwomen with lipedema across a spectrum of body weights
Conditionlipedema
Exposureketogenic / low-carbohydrate diet
Outcomeinsulin resistance (HOMA-IR), body composition/SAT area, pain (NRS)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log